LU75913A1 - - Google Patents

Info

Publication number
LU75913A1
LU75913A1 LU75913A LU75913A LU75913A1 LU 75913 A1 LU75913 A1 LU 75913A1 LU 75913 A LU75913 A LU 75913A LU 75913 A LU75913 A LU 75913A LU 75913 A1 LU75913 A1 LU 75913A1
Authority
LU
Luxembourg
Application number
LU75913A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75913A1 publication Critical patent/LU75913A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
LU75913A 1975-10-02 1976-09-30 LU75913A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2543994A DE2543994C3 (de) 1975-10-02 1975-10-02 Proteinmodifizierte Verbindungen des schwangerschaftsspezifischen ß, -Glykoproteins und deren Verwendung als Bestandteil von immunisierenden Mitteln

Publications (1)

Publication Number Publication Date
LU75913A1 true LU75913A1 (en:Method) 1977-05-11

Family

ID=5958064

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75913A LU75913A1 (en:Method) 1975-10-02 1976-09-30

Country Status (16)

Country Link
JP (1) JPS5290613A (en:Method)
AT (1) AT352756B (en:Method)
AU (1) AU511175B2 (en:Method)
BE (1) BE846928A (en:Method)
DE (1) DE2543994C3 (en:Method)
DK (1) DK444576A (en:Method)
FI (1) FI762790A7 (en:Method)
FR (1) FR2326203A1 (en:Method)
GB (1) GB1560633A (en:Method)
IL (1) IL50589A (en:Method)
IT (1) IT1070582B (en:Method)
LU (1) LU75913A1 (en:Method)
NL (1) NL7610688A (en:Method)
NO (1) NO763361L (en:Method)
NZ (1) NZ182193A (en:Method)
SE (1) SE7610892L (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191533A (en) * 1971-09-29 1980-03-04 Behringwerke Aktiengesellschaft Pregnancy-specific β1 -glycoprotein and process for isolating it
DE3525926A1 (de) 1985-07-19 1987-01-29 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von pankreas-alpha-amylase
EP2814499A4 (en) * 2012-02-17 2015-10-21 Castech Lab Llc PURIFICATION PROCESS

Also Published As

Publication number Publication date
AU1831876A (en) 1978-04-06
DK444576A (da) 1977-04-03
FR2326203A1 (fr) 1977-04-29
DE2543994B2 (de) 1979-02-15
DE2543994A1 (de) 1977-04-07
FI762790A7 (en:Method) 1977-04-03
IL50589A0 (en) 1976-11-30
ATA731176A (de) 1979-03-15
AU511175B2 (en) 1980-07-31
FR2326203B1 (en:Method) 1980-10-31
BE846928A (fr) 1977-04-04
NZ182193A (en) 1979-03-28
AT352756B (de) 1979-10-10
SE7610892L (sv) 1977-04-03
IL50589A (en) 1980-10-26
JPS5290613A (en) 1977-07-30
NL7610688A (nl) 1977-04-05
IT1070582B (it) 1985-03-29
GB1560633A (en) 1980-02-06
DE2543994C3 (de) 1979-10-11
NO763361L (en:Method) 1977-04-05

Similar Documents

Publication Publication Date Title
FR2326203B1 (en:Method)
JPS5417273Y2 (en:Method)
CH605954A5 (en:Method)
BG22025A2 (en:Method)
CH589705A5 (en:Method)
CH591894A5 (en:Method)
CH592318A5 (en:Method)
CH592761A5 (en:Method)
CH593644A5 (en:Method)
CH593673A5 (en:Method)
CH594585A5 (en:Method)
CH595056A5 (en:Method)
CH595302A5 (en:Method)
CH595592A5 (en:Method)
CH596890A5 (en:Method)
CH597672A5 (en:Method)
CH598603A5 (en:Method)
CH598732A5 (en:Method)
CH599739A5 (en:Method)
CH599916A5 (en:Method)
CH600625A5 (en:Method)
CH600949A5 (en:Method)
CH601158A5 (en:Method)
CH601541A5 (en:Method)
CH601610A5 (en:Method)